Drug Profile
Milameline
Alternative Names: CI 979; Mirameline; PD 129409; RU 35926; VivadLatest Information Update: 18 Sep 2000
Price :
$50
*
At a glance
- Originator Aventis
- Class Nootropics
- Mechanism of Action Muscarinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 18 Sep 2000 Discontinued-III for Alzheimer's disease in European Union (PO)
- 18 Sep 2000 Discontinued-III for Alzheimer's disease in USA (PO)
- 21 Jun 2000 Warner-Lambert has merged with Pfizer